Skip to main content
Premium Trial:

Request an Annual Quote

ETH Zurich Licenses DNAStar's Lasergene for Sequence Analysis


DNAStar said this week that the Swiss Federal Institute of Technology, or ETH, Zurich has selected its Lasergene software for sequence analysis.

The financial terms of the license agreement were not disclosed.

The Lasergene DNA and protein sequence analysis software is comprised of eight applications including tools for sequence assembly and SNP detection, automated virtual cloning, and primer design.

Other institutions that have licensed the product for their genomic analysis projects this year include Monash University (BI 12/2/2011) and the University of Texas (BI 11/11/2011).

The ETH Zurich agreement is the first European deal disclosed since the company this summer terminated a 15-year agreement that authorized GATC Biotech to distribute Lasergene in several European countries, opting instead to market its products directly to customers in those markets (BI 7/22/2011).

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.